Join us at 7pm tonight!
Neal vanderee officiator at the church of perpetual life.
Continue reading “The Pursuit of Immortality, Regeneration & Longevity” »
You might think we’re not in Texas anymore but in some strange episode of Black Mirror, the Netflix series, says Nikos Acuna who is moderating this SXSW panel on transhumanism.
In fact you’d be forgiven if you did as there is talk about cryo-preserving the body after being declared dead, in the hopes you can be resurrected when the science is here to safely defrost your body and cure you of your ailments. There is also talk on mind uploading, and replacing parts of our brains with neural prosthetics. This all sounds like science-fiction but these days the stuff of science fiction has become fact.
Transhumanist technologies are about overcoming the limitations of human biology and Dr Max More and Dr Randal Koene are at the forefront of these technologies.
BY HANK PELLISSIER
Hank Pellissier
Editor’s Note: The U.S. Transhumanist Party / Transhuman Party features this proposal by our member Hank Pellissier for a new website called Paradise2040, which will focus on the abolition of involuntary suffering and incremental ways of getting there within the next 21 years. This is an endeavor supported by Article IV of the Transhumanist Bill of Rights, Version 3.0. It is also a current within transhumanist thinking that, as Mr. Pellissier points out, could bring additional support to the movement. Different transhumanists will have different views as to what the most important aims of transhumanism should be. As an organization that embraces pluralism and diversity of thought, the U.S. Transhumanist Party / Transhuman Party would encourage any of our members who agree with the direction Mr. Pellissier proposes to collaborate with him on the creation of the Paradise2040 website.
~ Gennady Stolyarov II, Chairman, United States Transhumanist Party / Transhuman Party, March 25, 2019
https://paper.li/e-1437691924#/ https://www.nature.com/articles/s41591-019-0375-9
The hippocampus is one of the most affected areas in Alzheimer’s disease (AD). Moreover, this structure hosts one of the most unique phenomena of the adult mammalian brain, namely, the addition of new neurons throughout life. This process, called adult hippocampal neurogenesis (AHN), confers an unparalleled degree of plasticity to the entire hippocampal circuitry3,4. Nonetheless, direct evidence of AHN in humans has remained elusive. Thus, determining whether new neurons are continuously incorporated into the human dentate gyrus (DG) during physiological and pathological aging is a crucial question with outstanding therapeutic potential. By combining human brain samples obtained under tightly controlled conditions and state-of-the-art tissue processing methods, we identified thousands of immature neurons in the DG of neurologically healthy human subjects up to the ninth decade of life. These neurons exhibited variable degrees of maturation along differentiation stages of AHN. In sharp contrast, the number and maturation of these neurons progressively declined as AD advanced. These results demonstrate the persistence of AHN during both physiological and pathological aging in humans and provide evidence for impaired neurogenesis as a potentially relevant mechanism underlying memory deficits in AD that might be amenable to novel therapeutic strategies.
A new review discusses how neutrophils release toxic substances into the body under inflammatory conditions, detailing one of the ways in which chronic inflammation causes long-term damage.
Casting a deadly NET
As we age, we suffer from the ever-increasing chronic inflammation known as inflammaging. This persistent, smoldering background of low-grade inflammation harms wound healing and promotes multiple age-related diseases. Senescent cells, a weakened immune system, and chronic infections are all proposed to contribute to inflammaging.
Continue reading “Chronic Inflammation Leads to Toxic NET Buildup” »
The presence of senescent cells has been implicated in a wide range of age-related diseases and even conditions such as T1 diabetes. Today, we want to draw your attention to a new publication that explores the relationship between senescent cells and intervertebral disc degeneration (IDD).
It was already known that senescent cells increase during the progression of IDD, but it was not known if they were a driver or a consequence of IDD.
The findings, published on February 18, 2019 in the journal Nature Medicine, highlight a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed in mice with Hutchinson-Gilford progeria syndrome, a rare genetic disorder that also afflicts humans. This treatment provides important insight into the molecular pathways involved in accelerated aging, as well as how to reduce toxic proteins via gene therapy.
“Aging is a complex process in which cells start to lose their functionality, so it is critical for us to find effective ways to study the molecular drivers of aging,” says Juan Carlos Izpisua Belmonte, a professor in Salk’s Gene Expression Laboratory and senior author of the paper. “Progeria is an ideal aging model because it allows us to devise an intervention, refine it and test it again quickly.”
With an early onset and fast progression, progeria is one of the most severe forms of a group of degenerative disorders caused by a mutation in the LMNA gene. Both mice and humans with progeria show many signs of aging, including DNA damage, cardiac dysfunction and dramatically shortened life span. The LMNA gene normally produces two similar proteins inside a cell: lamin A and lamin C. Progeria shifts the production of lamin A to progerin. Progerin is a shortened, toxic form of lamin A that accumulates with age and is exacerbated in those with progeria.
On July 11-12th, we return to the Cooper Union in New York City for our second annual Ending Age-Related Diseases conference, which focuses on the progress in aging research as well as the business side of biotech.
We will be bringing you the latest aging research, investment, and business knowledge from some of the top experts in the industry. We will be packing two days full of talks and discussion panels featuring the people who are developing the technologies that could change the way we regard and treat aging forever.
We are currently offering reduced ticket prices until March 31st, after which the price increases to the regular $400 cost. If you would like to take advantage of this special offer, head on over to our event ticket page to secure your place now.
Continue reading “Ending Age-Related Diseases Conference: March Update” »
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine. The research, led by Wyss Institute Core Faculty member David Mooney, Ph.D., lays the foundation for a host of clinical applications in restorative dentistry and regenerative medicine more broadly, such as wound healing, bone regeneration, and more.
